References
- MillerMAPisaniEThe cost of unsafe injectionsBull World Health Organ1999771080881110593028
- PrausnitzMRLangerRTransdermal drug deliveryNat Biotechnol200826111261126818997767
- LiNPengLHChenXNakagawaSGaoJQTranscutaneous vaccines: novel advances in technology and delivery for overcoming the barriersVaccine201129376179619021740946
- PeachmanKKRaoMAImmunization with DNA through the skinMethods200331323224214511956
- BalSMDingZvan RietEJiskootWBouwstraJAAdvances in transcutaneous vaccine delivery: do all ways lead to Rome?J Control Release2010148326628220869998
- GlennGMScharton-KerstenTAlvingCRAdvances in vaccine delivery: transcutaneous immunisationExpert Opin Investig Drugs199986797805
- GuptaPNMishraVRawatANon-invasive vaccine delivery in transfersomes, niosomes and liposomes: a comparative studyInt J Pharm20052931–2738215778046
- IshiiYNakaeTSakamotoFA transcutaneous vaccination system using a hydrogel patch for viral and bacterial infectionJ Control Release2008131211312018700159
- MatsuoKKoizumiHAkashiMIntranasal immunization with poly(γ-glutamic acid) nanoparticles entrapping antigenic proteins can induce potent tumor immunityJ Control Release2011152231031621402114
- YoshikawaTImazuSGaoJQNon-methylated CpG motif packaged into fusogenic liposomes enhance antigen-specific immunity in mice. DNA vaccineBiol Pharm Bull200629110510916394520
- YoshikawaTOkadaNTsujinoMVaccine efficacy of fusogenic liposomes containing tumor cell-lysate against murine B16BL6 melanomaBiol Pharm Bull200629110010416394519
- SugitaTYoshikawaTGaoJQFusogenic liposome can be used as an effective vaccine carrier for peptide vaccination to induce cytotoxic T lymphocyte (CTL) responseBiol Pharm Bull200528119219315635192
- YoshikawaTImazuSGaoJQAugmentation of antigen-specific immune responses using DNA-fusogenic liposome vaccineBiochem Biophys Res Commun2004325250050515530420
- MatsuoKIshiiYQuanYSTranscutaneous vaccination using a hydrogel patch induces effective immune responses to tetanus and diphtheria toxoid in hairless ratJ Control Release20111491152020493218
- YoshikawaTOkadaNOdaANanoparticles built by self-assembly of amphiphilic gamma-PGA can deliver antigens to antigen-presenting cells with high efficiency: a new tumor-vaccine carrier for eliciting effector T cellsVaccine200826101303131318255205
- YoshikawaTOkadaNOdaADevelopment of amphiphilic gamma-PGA-nanoparticle based tumor vaccine: potential of the nanoparticulate cytosolic protein delivery carrierBiochem Biophys Res Commun2008366240841318068668
- MatsuoKYoshikawaTOdaAEfficient generation of antigen-specific cellular immunity by vaccination with poly(gamma-glutamic acid) nanoparticles entrapping endoplasmic reticulum-targeted peptidesBiochem Biophys Res Commun200736241069107217822676
- RamprasadMPAminiAKararliTKatreNVThe sustained granulopoietic effect of progenipoietin encapsulated in multivesicular liposomesInt J Pharm20032611–29310312878398
- SegotaSTezakDSpontaneous formation of vesiclesAdv Colloid Interface Sci20061211–3517516769012
- BadieeAJaafariMRKhamesipourALeishmania major: Immune response in BALB/c mice immunized with stress-inducible protein 1 encapsulated in liposomesExp Parasitol2007115212713416979165
- XieYYeLZhangXTransport of nerve growth factor encapsulated into liposomes across the blood-brain barrier: In vitro and in vivo studiesJ Control Release20051051–210611915893839
- García-SantanaMADucongeJSarmientoMEBiodistribution of liposome-entrapped human gamma-globulinBiopharm Drug Dispos200627627528316758502
- MishraDDubeyVAsthanaASarafDKJainNKElastic liposomes mediated transcutaneous immunization against Hepatitis BVaccine200624224847485516600441
- WangJHuJHLiFStrong cellular and humoral immune responses induced by transcutaneous immunization with HBsAg DNA-cationic deformable liposome complexExp Dermatol200716972472917697144
- DuncanMRLeeJMWarcholMPInfluence of surfactants upon protein/peptide adsorption to glass and polypropyleneInt J Pharm19951202179188
- HuFQHongYYuanHPreparation and characterization of solid lipid nanoparticles containing peptideInt J Pharm20042731–2293515010127
- DingZBalSMRomeijnSKerstenGFJiskootWBouwstraJATranscutaneous immunization studies in mice using diphtheria toxoid-loaded vesicle formulations and a microneedle arrayPharm Res201128114515820237826
- MishraVMahorSRawatADevelopment of novel fusogenic vesosomes for transcutaneous immunizationVaccine20062427–285559557016730102
- GuanKLYuWLinYXiongYZhaoSGeneration of acetyllysine antibodies and affinity enrichment of acetylated peptidesNature Protoc2010591583159521085124
- NishimuraKOhtsuruMNigotaKEffect of dehydroascorbic acid on ovalbuminJ Agri Food Chem198937615391543
- WilliamsNAImmune modulation by the cholera-like enterotoxin B-subunits: from adjuvant to immunotherapeuticInt J Med Microbiol20002904–544745311111925
- ManningBMEnioutinaEYVisicDMKnudsonADDaynesRACpG DNA functions as an effective adjuvant for the induction of immune responses in aged miceExp Gerontol200137110712611738152
- SeyaTAkazawaTTsujitaTMatsumotoMRole of Toll-like receptors in adjuvant-augmented immune therapiesEvid Based Complement Alternat Med200631313816550221
- ShackletonMDavisIDHopkinsWThe impact of imiquimod, a Toll-like receptor-7 ligand (TLR7 L), on the immunogenicity of melanoma peptide vaccination with adjuvant Flt3 ligandCancer Immun20044915384929
- WargerTRechtsteinerGSchmidBOsterlohPSchildHRadsakMPTranscutaneous immunization with imiquimod is amplified by CD40 ligation and results in sustained cytotoxic T-lymphocyte activation and tumor protectionClin Rev Allergy Immunol2007321576617426361
- MaheBVogtALiardCNanoparticle-based targeting of vaccine compounds to skin antigen-presenting cells by hair follicles and their transport in miceJ Invest Dermatol200912951156116419052565